» Articles » PMID: 34046867

The Disorders of Endometrial Receptivity in PCOS and Its Mechanisms

Overview
Journal Reprod Sci
Publisher Springer
Date 2021 May 28
PMID 34046867
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Polycystic ovary syndrome (PCOS) is a mysterious and complicated endocrine disease with the combination of metabolic, reproductive, psychological dysfunctions. Impaired endometrial receptivity and ovulation disorders/anovulation are both important causes of PCOS-related infertility. However, change in endometrium has never received the same attention as ovulatory dysfunction. Besides, putting emphasis on endometrial function may be more realistic for PCOS-related infertility, given the wide use of assisted reproductive technology. The present review focuses on the disorders of endometrial receptivity of patients with PCOS, summarizes the changes of the indicators of endometrial receptivity including leukemia inhibitory factor, homeobox genes A, pinopodes, αvβ3-integrin, and intercellular junctions and also analyzes the possible mechanisms of decreased endometrial receptivity and its relationship with the main endocrine and metabolic disorders of PCOS such as hyperandrogenism, inflammation, insulin resistance, and obesity. Despite several biomarkers have been found to be associated with decreased endometrial receptivity in PCOS, the clinical relevance of these findings still awaits future clarification.

Citing Articles

Metabolism-related proteins as biomarkers for predicting prognosis in polycystic ovary syndrome.

Ding N, Wang R, Wang P, Wang F Proteome Sci. 2024; 22(1):14.

PMID: 39702179 PMC: 11660692. DOI: 10.1186/s12953-024-00238-9.


Supraphysiological Dose of Testosterone Impairs the Expression and Distribution of Sex Steroid Receptors during Endometrial Receptivity Development in Female Sprague-Dawley Rats.

Yusuf A, Amri M, Ugusman A, A Hamid A, Mokhtar M Int J Mol Sci. 2024; 25(18).

PMID: 39337689 PMC: 11432676. DOI: 10.3390/ijms251810202.


Correlation analysis of BMI with ovulation effect and clinical pregnancy rate in patients with polycystic ovary syndrome.

Zeng X, Yang C Am J Transl Res. 2024; 16(8):4174-4181.

PMID: 39262693 PMC: 11384404. DOI: 10.62347/KYES1276.


Effect of GnRH agonist down-regulation combined with hormone replacement treatment on reproductive outcomes of frozen blastocyst transfer cycles in women of different ages.

Xie J, Lu J, Zhang H PeerJ. 2024; 12:e17447.

PMID: 38832029 PMC: 11146325. DOI: 10.7717/peerj.17447.


AI-algorithm training and validation for identification of endometrial CD138+ cells in infertility-associated conditions; polycystic ovary syndrome (PCOS) and recurrent implantation failure (RIF).

Lee S, Arffman R, Komsi E, Lindgren O, Kemppainen J, Metsola H J Pathol Inform. 2024; 15:100380.

PMID: 38827567 PMC: 11140811. DOI: 10.1016/j.jpi.2024.100380.


References
1.
Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz B . The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016; 31(12):2841-2855. DOI: 10.1093/humrep/dew218. View

2.
Eden J . The polycystic ovary syndrome presenting as resistant acne successfully treated with cyproterone acetate. Med J Aust. 1991; 155(10):677-80. DOI: 10.5694/j.1326-5377.1991.tb93959.x. View

3.
Ashkenazi J, Farhi J, Orvieto R, Homburg R, Dekel A, Feldberg D . Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient. Fertil Steril. 1995; 64(3):564-7. DOI: 10.1016/s0015-0282(16)57793-0. View

4.
Wilcox A, Baird D, Weinberg C . Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999; 340(23):1796-9. DOI: 10.1056/NEJM199906103402304. View

5.
Griffiths R, Pru C, Behura S, Cronrath A, McCallum M, Kelp N . AMPK is required for uterine receptivity and normal responses to steroid hormones. Reproduction. 2020; 159(6):707-717. PMC: 7259611. DOI: 10.1530/REP-19-0402. View